Prostate cancer screening - Stockholm-3

Background: Prostate cancer is one of the most common cancers among older men. In Sweden screening, testing of large groups of the population, for prostate cancer has so far not been implemented. A reason for this being the difficulties in how to assess the traditional marker for prostate cancer (PSA) that has thus far been the most widely used marker. In different parts of the world other tests has been developed in an attempt to replace or to add an extra level of knowledge to the PSA test to improve diagnosis. At Karolinska Institute in Stockholm a test called Stockholm-3 or Sthlm3 has been developed. The test consists of 5 protein markers and over 100 genetic markers together with clinical data to assess the risk that one has an in need of treatment and severe prostate cancer. Read more at sthlm3.se
If you have or have had prostate cancer this test is not recommended for you.
Among the benefits of Sthlm3 are:

• Finds more men with severe cancer
• Decrease the number of men that need to have a biopsy/tissue sample taken.
• Can find severe cancer in cases with a low PSA.
• Gives a clear result and recommendation and a better assessment of the individual risk of getting severe prostate cancer

How is the test done: Common (venous) blood sample.
When do I get the result: Usually within 5-6 weeks.
Price: 3 850 SEK
How do I make an appointment: Contact us here or at info@gendoktorn.se
Where is the analysis performed: Uppsala, Sweden

Please note: For the complete test to be performed a PSA-value of at least 1.5µg/l is required, otherwise the analysis will be stopped due to the risk of prostate cancer being considered to be negligible.
Due to this reason we recommend that before making an appointment with us you already have taken a PSA-test with a level of at least 1.5µg/l (e.g. at your vårdcentral).